AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific.
The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products.
Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment.
The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence.
It serves various academic, government, biopharmaceutical, biotechnology, and other institutions.
The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Country | United States |
IPO Date | Sep 12, 2019 |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 1,259 |
CEO | Dr. Serge Saxonov Ph.D. |
Contact Details
Address: 6230 Stoneridge Mall Road Pleasanton, California United States | |
Website | https://www.10xgenomics.com |
Stock Details
Ticker Symbol | TXG |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001770787 |
CUSIP Number | 88025U109 |
ISIN Number | US88025U1097 |
Employer ID | 45-5614458 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Dr. Serge Saxonov Ph.D. | Co-Founder, Chief Executive Officer & Director |
Adam S. Taich | Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer |
Alexander Wong | Chief Information Officer |
Eric S. Whitaker Esq. | Chief Legal Officer |
Michael Schnall-Levin | Founding Scientist & Chief Technology Officer |
Rebecca Port | Chief People Officer |
Cassie Corneau | Manager of Investor Relations & Strategic Finance |
Dr. Benjamin J. Hindson Ph.D. | Co-Founder, President, Chief Scientific Officer & Director |
Jim Goodrich | Chief of Global Operations |
Mennah Moustafa | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 23, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 05, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Oct 29, 2024 | 10-Q | Quarterly Report |
Oct 29, 2024 | 8-K | Current Report |
Oct 09, 2024 | 8-K | Current Report |
Oct 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |